NanoViricides
NNVC
#10070
Rank
HK$0.19 B
Marketcap
HK$9.25
Share price
0.00%
Change (1 day)
-20.59%
Change (1 year)

NanoViricides (NNVC) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : HK$9.18 Million

According to NanoViricides's latest financial reports the company's total liabilities are HK$9.18 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

NanoViricides - Total liabilities on balance sheet (from 2006 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-06-30HK$10.61 M-33.44%
2023-06-30HK$15.94 M392.04%
2022-06-30HK$3.23 M18.82%
2021-06-30HK$2.72 M-83.69%
2020-06-30HK$16.71 M-24.88%
2019-06-30HK$22.24 M221.44%
2018-06-30HK$6.92 M-86.73%
2017-06-30HK$52.15 M-50.52%
2016-06-30HK$0.10 B9.67%
2015-06-30HK$96.12 M-39.47%
2014-06-30HK$0.15 B143.81%
2013-06-30HK$65.13 M371.79%
2012-06-30HK$13.8 M202.12%
2011-06-30HK$4.56 M-76.28%
2010-06-30HK$19.26 M382.05%
2009-06-30HK$3.99 M-49.97%
2008-06-30HK$7.98 M20.26%
2007-06-30HK$6.64 M-42.65%
2006-06-30HK$11.58 M2158.19%
2005-06-30HK$0.51 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
BioCryst Pharmaceuticals
BCRX
HK$6.48 B 70,461.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
HK$10.38 B 112,938.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
HK$288.11 B 3,135,667.39%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$608.36 B 6,621,150.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
HK$603.30 B 6,566,176.78%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$476.22 B 5,182,995.26%๐Ÿ‡ฌ๐Ÿ‡ง UK